Stockscreener 앱 받기
5.17
5.83%
-0.32
시간 외 거래:
5.11
-0.06
-1.16%
전일 마감가:
$5.49
열려 있는:
$5.195
하루 거래량:
5.63M
Relative Volume:
0.88
시가총액:
$1.11B
수익:
$2.59M
순이익/손실:
$-137.89M
주가수익비율:
-6.3827
EPS:
-0.81
순현금흐름:
$-69.76M
1주 성능:
+9.53%
1개월 성능:
+9.07%
6개월 성능:
+229.30%
1년 성능:
+338.14%
1일 변동 폭
$5.02
$5.31
1주일 범위
$4.77
$5.965
52주 변동 폭
$1.03
$5.965
Atai Life Sciences N V Stock (ATAI) Company Profile
명칭
Atai Life Sciences N V
전화
49 89 2153 9035
주소
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
ATAI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATAI
Atai Life Sciences N V
|
5.17 | 1.18B | 2.59M | -137.89M | -69.76M | -0.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-29 | 개시 | Oppenheimer | Outperform |
| 2024-11-18 | 재확인 | H.C. Wainwright | Buy |
| 2024-04-03 | 업그레이드 | Maxim Group | Hold → Buy |
| 2022-11-01 | 개시 | Loop Capital | Buy |
| 2021-11-30 | 개시 | Maxim Group | Buy |
| 2021-11-11 | 개시 | ROTH Capital | Buy |
| 2021-10-18 | 개시 | H.C. Wainwright | Buy |
| 2021-09-01 | 개시 | Jefferies | Buy |
| 2021-07-13 | 개시 | Berenberg | Buy |
| 2021-07-13 | 개시 | Canaccord Genuity | Buy |
| 2021-07-13 | 개시 | Cantor Fitzgerald | Buy |
| 2021-07-13 | 개시 | Citigroup | Buy |
| 2021-07-13 | 개시 | Cowen | Outperform |
| 2021-07-13 | 개시 | Credit Suisse | Outperform |
| 2021-07-13 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-07-08 | 개시 | Aegis Capital | Buy |
모두보기
Atai Life Sciences N V 주식(ATAI)의 최신 뉴스
Canaccord Genuity reaffirms Buy rating on atai Life Sciences stock - Investing.com
atai Life Sciences stock rating reiterated at Buy by H.C. Wainwright - Investing.com
atai and Beckley’s psychedelic advances to pivotal TRD trial - Yahoo Finance
Alibaba, Lithium Americas And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session - Benzinga
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression - markets.businessinsider.com
Atai Life Sciences N.V. (ATAI) Advances Psychedelic Therapies for Mental Health, Drawing Investor Spotlight - Yahoo Finance
Atai Life Sciences Experimental Depression Drug Shows Sustained Benefit In Treatment-Resistant Patients - Yahoo Finance
ATAI Life Sciences (ATAI) Stock Maintains 'Buy' Rating by HC Wai - GuruFocus
atai Life Sciences rises after promising data from depression trial - Seeking Alpha
Atai, Beckley Report Positive Phase 2a Results for Intranasal BPL-003 in Treatment-Resistant Depression - MarketScreener
atai's BPL-003 Shows 50% Remission Rate in Phase 2a Depression Trial | ATAI Stock News - Stock Titan
H.C. Wainwright Affirms ‘Buy’ Rating on Atai Life Sciences N.V. (ATAI) on Psychedelic Prospects - Insider Monkey
Risk Report: Can Atai Life Sciences NV stock outperform in a bear marketWeekly Stock Summary & Weekly Watchlist for Consistent Profits - خودرو بانک
Are Medical Stocks Lagging atai Life Sciences (ATAI) This Year? - Yahoo Finance
NIDA boost for Atai’s 5-HT2A/2C receptor agonists - BioWorld MedTech
Atai Life Sciences awarded grant worth up to $11.4M from NIH - Yahoo Finance
Bearish Setup: Is Atai Life Sciences NV a speculative investmentPortfolio Return Report & AI Powered Buy/Sell Recommendations - khodrobank.com
Day Trade: Why is Atai Life Sciences NV stock going upWeekly Profit Summary & Weekly Market Pulse Alerts - خودرو بانک
Earnings Recap: What are Atai Life Sciences N.V.’s recent SEC filings showingMarket Growth Report & AI Forecasted Entry and Exit Points - خودرو بانک
atai Life Sciences Awarded Grant from the National Institutes of Health - Investing News Network
Growth Report: Can Atai Life Sciences NV continue delivering strong returnsTrade Performance Summary & Verified Momentum Stock Ideas - khodrobank.com
Bond Watch: Is Atai Life Sciences NV undervalued by DCF analysisJuly 2025 Earnings & Precise Swing Trade Alerts - خودرو بانک
Aug Patterns: Can Atai Life Sciences NV expand into new marketsPortfolio Risk Report & High Conviction Trade Alerts - خودرو بانک
Pharma News: Can Atai Life Sciences NV continue delivering strong returnsEarnings Summary Report & AI Enhanced Trading Signals - خودرو بانک
Nasdaq Moves: Is Teekay Tankers Ltd stock showing strong momentumTrend Reversal & Daily Price Action Insights - khodrobank.com
Big Picture: What are Atai Life Sciences N.V.’s recent SEC filings showing2025 Historical Comparison & Capital Protection Trade Alerts - khodrobank.com
H.C. Wainwright reaffirms Buy rating on atai Life Sciences stock at $15 target - Investing.com Canada
atai Life Sciences to Participate in September Investor Conferences - Investing News Network
Is Atai Life Sciences N.V. stock a smart buy before Fed meetingJuly 2025 PreEarnings & Risk Managed Investment Strategies - baoquankhu1.vn
atai Life Sciences (ATAI) Upgraded to Buy: Here's What You Should Know - sharewise.com
Is a relief rally coming for Atai Life Sciences N.V. holdersJuly 2025 Update & Low Drawdown Trading Techniques - Newser
Statistical indicators supporting Atai Life Sciences N.V.’s strengthJuly 2025 Price Swings & AI Based Buy and Sell Signals - Newser
Tools to monitor Atai Life Sciences N.V. recovery probabilityMarket Performance Report & Weekly Breakout Opportunity Watchlist - Newser
Can a trend reversal in Atai Life Sciences N.V. lead to recoveryJuly 2025 Opening Moves & AI Optimized Trade Strategies - Newser
Does Atai Life Sciences N.V. offer margin of safetyPortfolio Risk Report & Long Hold Capital Preservation Tips - خودرو بانک
Will a bounce in Atai Life Sciences N.V. offer an exitJuly 2025 Gainers & Capital Protection Trading Alerts - Newser
Is Atai Life Sciences N.V. a defensive stockJuly 2025 Recap & Stepwise Trade Signal Implementation - خودرو بانک
What data driven models say about Atai Life Sciences N.V.’s future - Newser
Historical volatility pattern of Atai Life Sciences N.V. visualizedEarnings Miss & Consistent Profit Trading Strategies - Newser
Can Atai Life Sciences N.V. hit a new high this monthShare Buyback & Free Verified High Yield Trade Plans - Newser
What institutional flow reveals about Atai Life Sciences N.V.Oil Prices & Growth Focused Stock Reports - Newser
Volatility clustering patterns for Atai Life Sciences N.V.Trade Ideas & Fast Moving Market Watchlists - Newser
Movement Recap: What are Atai Life Sciences N.V.’s recent SEC filings showingMarket Sentiment Summary & Risk Controlled Daily Trade Plans - خودرو بانک
Published on: 2025-09-04 08:51:35 - Newser
How moving averages guide Atai Life Sciences N.V. tradingGlobal Markets & Detailed Earnings Play Alerts - Newser
How hedge fund analytics apply to Atai Life Sciences N.V. stock2025 Price Targets & Advanced Swing Trade Entry Alerts - Newser
Using R and stats models for Atai Life Sciences N.V. forecasting2025 Buyback Activity & Daily Growth Stock Tips - Newser
Combining price and volume data for Atai Life Sciences N.V.Weekly Gains Summary & Short-Term Swing Trade Alerts - Newser
Does Atai Life Sciences N.V. qualify in momentum factor screeningRate Cut & Weekly Chart Analysis and Trade Guides - Newser
Applying big data sentiment scoring on Atai Life Sciences N.V.Market Performance Summary & Real-Time Stock Entry Alerts - Newser
What are the analyst revisions for Atai Life Sciences N.V.Is OSTX stock a good investment in YEARQuarterly Profit Summary & Free Verified High Yield Trade Plans - خودرو بانک
Atai Life Sciences N V (ATAI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.43%
자본화:
|
볼륨(24시간):